A pharmacist-driven antimicrobial approval program at a Veterans Affairs hospital

American Journal of Health-System Pharmacy

Volumn 60, Issue 13, 2003, Pages 1358-1362

  Cannon, Joan P ^a   Silverman, Robert M ^a  

^a HINES VA HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIMICROBIAL THERAPY; ARTICLE; COST MINIMIZATION ANALYSIS; DRUG COST; HEALTH CARE SYSTEM; HOSPITAL MANAGEMENT; HUMAN; INFECTION; MEDICAL PRACTICE; PATIENT CARE; PHARMACEUTICAL CARE; PHARMACIST; PRIORITY JOURNAL; ECONOMICS; HOSPITAL PHARMACY; ORGANIZATION AND MANAGEMENT; PRACTICE GUIDELINE; PUBLIC HOSPITAL;

ANTI-INFECTIVE AGENTS; HOSPITALS, VETERANS; PHARMACISTS; PHARMACY SERVICE, HOSPITAL; PRACTICE GUIDELINES;

EID: 0242305030     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/60.13.1358     Document Type: Article

References (16)

1. Agency for Healthcare Research and Quality. Healthcare Cost & Utilization Project. www.ahcpr.gov/data/hcup/ (accessed 2002 Mar 22).
2. Duong LP. Comparison of the cost impact of infectious disease physicians and clinical pharmacists in antibiotic monitoring in a community hospital. P&T. 2000; 25:346-50.
3. Woodward RS, Medoff G, Smith MD et al. Antibiotic cost savings from formulary restrictions and physician monitoring in a medical-school-affiliated hospital. Am J Med. 1987; 83:817-23.
4. Michael KA, Henderson PL, Newman RB et al. Impact of a pharmacist/physician cooperative target drug monitoring program on prophylactic antibiotic prescribing in obstetrics and gynecology. Hosp Pharm. 1992; 27:213-6.
5. White AC Jr, Atmar RL, Wilson J et al. Effects of prior authorization for selected antimicrobials: expenditures, susceptibilities, and clinical outcomes. Clin Infect Dis. 1997; 25:230-9.
6. Coleman RW, Rodondi LC, Kaubisch S et al. Cost-effectiveness of prospective and continuous parenteral antibiotic control: experience at the Palo Alto Veterans Affairs Medical Center from 1987 to 1989. Am J. Med. 1991; 90:439-44.
7. Gums JG, Yancey RW Jr, Hamilton CA et al. A randomized, prospective study measuring outcomes after antibiotic therapy intervention by a multidisciplinary consult team. Pharmacotherapy. 1999; 19:1369-77.
8. Craig WA, Uman SJ, Shaw WR et al. Hospital use of antimicrobial drugs. Ann Intern Med. 1978; 89(5 pt 2 suppl):793-5.
9. Maswoswe JJ, Okpara AU. Enforcing a policy for restricting antimicrobial drug use. Am J Health-Syst Pharm. 1995; 52:1433-5.
10. Fraser GL, Stogsdill P, Dickens JD Jr et al. Antibiotic optimization. An evaluation of patient safety and economic outcomes. Arch Intern Med. 1997; 157:1689-94.
11. Avorn J, Soumerai SB, Taylor W et al. Reduction of incorrect antibiotic dosing through a structured educational order form. Arch Intern Med. 1988; 148:1720-4.
12. Hirschman SZ, Meyers BR, Bradbury K et al. Use of antimicrobial agents in a university teaching hospital. Evolution of a comprehensive control program. Arch Intern Med. 1988; 148:2001-7.
13. Capers CC, Bess DT, Branam AC et al. Antibiotic surveillance: the results of a clinical pharmacy intervention program. Hosp Pharm. 1993; 28:206-12.
14. Gentry CA, Greenfield RA, Slater LN et al. Outcomes of an antimicrobial control program in a teaching hospital. Am J Health-Syst Pharm. 2000; 57:268-74.
15. Rifenburg RP, Paladindo JA, Hanson SC et al. Benchmark analysis of strategies hospitals use to control antimicrobial expenditures. Am J Health-Syst Pharm. 1996; 53:2054-62.
16. Gould IM, Jappy B. Trends in hospital antimicrobial prescribing after 9 years of stewardship. J Antimicrob Chemother. 2000; 45:913-7.